Blue Chandra Sells Stake in Samhi Hotels Ahead of IPO, Priced at Rs 126 per Share

| Leave a Comment | IPO

Blue Chandra Pte Ltd, a Singapore-based investment firm, has reduced its stake in Samhi Hotels ahead of the company’s initial public offering (IPO). The stake reduction was part of a private placement of 1,03,17,460 equity shares in Samhi Hotels for Rs 130 crore. The shares were sold at a price of Rs 126 per share.

Prior to the stake reduction, Blue Chandra was the largest shareholder in Samhi Hotels with a 30.65% stake. As a result of the sale, its stake has reduced to 22.25%, making it the second largest shareholder after ACIC Mauritius, which holds a 30.51% stake.

The private placement was conducted to three investors: Madhuri Madhusudan Kela, wife of ace investor Madhusudan Kela; Nuvama Crossover Opportunities Fund; and TIMF Holdings.

The IPO of Samhi Hotels is scheduled to open for subscription from September 14-18. The company is looking to raise Rs 1,370.1 crore through the IPO, which comprises a fresh issuance of shares worth Rs 1,200 crore and an offer for sale (OFS) of 1.35 crore shares by Blue Chandra, Goldman Sachs Investments Holdings (Asia), and GTI Capital Alpha.

The proceeds from the IPO will be used to repay debts amounting to Rs 900 crore and the remaining for general corporate purposes.

Samhi Hotels is a hotel owner and asset manager that acquires or builds primarily business hotels. It then upgrades the properties and engages with established branded hotel operators to position the hotels in the market. The company has a portfolio of 3,839 keys across 25 operating hotels in 12 key urban consumption centres in India.

JM Financial and Kotak Mahindra Capital Company are the merchant bankers on the issue.

In addition to the above, I would like to add the following points:

  • The private placement of shares by Blue Chandra was conducted at a premium of 3.1% to the floor price of the IPO. This suggests that investors are optimistic about the prospects of Samhi Hotels and are willing to pay a premium for the shares.
  • The IPO of Samhi Hotels is expected to be one of the largest IPOs in India this year. The company is well-positioned to benefit from the growth of the Indian hospitality industry.
  • The IPO is also likely to be well-received by retail investors, as Samhi Hotels is a well-known brand in the Indian hospitality industry.

Related News

  • 20 Sep

    Sai Silks Kalamandir’s IPO subscribed just 7% on the first day

    Sai Silks Kalamandir's IPO subscribed just 7% on the first day of bidding, with retail investors and high net-worth individuals showing decent support, but qualified institutional buyers (QIBs) being lukewarm. The company aims to raise Rs 1,201 crore through its public issue, comprising a fresh issue of Rs 600 crore and an offer-for-sale (OFS) of Rs 601 crore by the promoter group. The price band for the offer has been fixed at Rs 210-222 per share. The net fresh issue proceeds will be used mainly for setting up new stores, building warehouses and working capital requirements. The company has a network of 54 outlets in Andhra Pradesh, Telangana, Karnataka and Tamil Nadu.

  • 20 Sep

    Yatra Online IPO subscribed 1.61 times, but aggressive pricing may have dampened demand

    Yatra Online's IPO subscribed 1.61 times on the final day of bidding, with retail investors providing decent support. However, QIBs and HNIs were less enthusiastic, possibly due to the aggressive pricing of the issue. Some brokerages remain positive on the company from a medium-to-long-term perspective, but investors should carefully consider the company's fundamentals, valuation, and risk factors before making an investment decision.

  • 20 Sep

    Pharma Company Valiant Laboratories to Launch IPO on September 27

    Pharma company Valiant Laboratories is launching its maiden public issue on September 27, 2023. The IPO will comprise only a fresh issue of 1.09 crore equity shares by the company and there will be no offer-for-sale portion in the issue. The net proceeds from the IPO will be used to set up a manufacturing facility for specialty chemicals in Bharuch, Gujarat and for general corporate purposes. The company recorded a profit of Rs 29 crore for the year ended March FY23, up by 5.5 percent from previous year, and the revenue from operations increased by 14.5 percent to Rs 333.9 crore during the same period. Valiant Laboratories' shares are expected to make their debut on the BSE and NSE on October 9, 2023.

  • 20 Sep

    Signature Global IPO: Key Details, Analyst Views, and Risks

    Signature Global (India), the largest real estate development company in the Delhi NCR region in affordable and lower mid-segment housing, is launching its IPO on September 20, 2023. The company plans to raise Rs 730 crore through the IPO, which will be listed on both the NSE and BSE. Analysts are divided on the Signature Global IPO. Some analysts believe that the company is well-positioned in the affordable and lower mid-segment housing market, while others are concerned about the company's net loss, negative net worth, and dependence on the real estate market in the Delhi- NCR region.

  • 20 Sep

    EMS Limited: A Good Investment Opportunity for Professional Investors

    EMS Limited, a water and wastewater management company, is expected to list strongly on September 21. The company's IPO was subscribed 75.28 times, driven by strong demand from qualified institutional buyers, high networth individuals, and retail investors. EMS has a proven track record of successful project execution and a strong order book. It also has a healthy financial position. Analysts are positive on the company and advise investors who are allotted shares to hold them from a medium to long term perspective. Professional investors should carefully consider the company's strong fundamentals and long-term growth outlook before making an investment decision.

Leave a Reply

Your email address will not be published. Required fields are marked *